An HIV vaccine candidate failed to prove efficacy in a phase 3 trial, and it’s now abandoned, according to Janssen, Johnson & Johnson’s pharmaceutical arm.
Read the full post on Becker's Hospital Review - Healthcare News
HIV vaccine trial halted after phase 3 failure
